FRASER & COMPANY | REMEDIUM LIFECARE | FRASER & COMPANY/ REMEDIUM LIFECARE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -17.1 | 13.7 | - | View Chart |
P/BV | x | 0.5 | 99.9 | 0.5% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
FRASER & COMPANY REMEDIUM LIFECARE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
FRASER & COMPANY Mar-23 |
REMEDIUM LIFECARE Mar-23 |
FRASER & COMPANY/ REMEDIUM LIFECARE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 11 | 738 | 1.5% | |
Low | Rs | 6 | 135 | 4.1% | |
Sales per share (Unadj.) | Rs | 12.9 | 1,416.2 | 0.9% | |
Earnings per share (Unadj.) | Rs | 0.4 | 15.1 | 2.8% | |
Cash flow per share (Unadj.) | Rs | 0.6 | 15.5 | 3.7% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 9.8 | 28.8 | 34.2% | |
Shares outstanding (eoy) | m | 8.12 | 3.60 | 225.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.6 | 0.3 | 204.3% | |
Avg P/E ratio | x | 19.3 | 28.9 | 66.8% | |
P/CF ratio (eoy) | x | 14.3 | 28.1 | 50.9% | |
Price / Book Value ratio | x | 0.8 | 15.1 | 5.5% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 66 | 1,570 | 4.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2 | 6 | 34.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 105 | 5,098 | 2.1% | |
Other income | Rs m | 0 | 8 | 0.2% | |
Total revenues | Rs m | 105 | 5,107 | 2.1% | |
Gross profit | Rs m | 7 | 72 | 9.2% | |
Depreciation | Rs m | 1 | 2 | 79.5% | |
Interest | Rs m | 1 | 4 | 17.1% | |
Profit before tax | Rs m | 5 | 74 | 6.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1 | 20 | 6.2% | |
Profit after tax | Rs m | 3 | 54 | 6.3% | |
Gross profit margin | % | 6.3 | 1.4 | 446.1% | |
Effective tax rate | % | 26.3 | 26.6 | 98.8% | |
Net profit margin | % | 3.3 | 1.1 | 306.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 114 | 11,541 | 1.0% | |
Current liabilities | Rs m | 41 | 11,439 | 0.4% | |
Net working cap to sales | % | 69.5 | 2.0 | 3,448.1% | |
Current ratio | x | 2.8 | 1.0 | 276.8% | |
Inventory Days | Days | 64 | 0 | - | |
Debtors Days | Days | 366,539,249 | 1,234 | 29,702,155.5% | |
Net fixed assets | Rs m | 21 | 1 | 2,737.2% | |
Share capital | Rs m | 81 | 36 | 225.6% | |
"Free" reserves | Rs m | -1 | 68 | -1.8% | |
Net worth | Rs m | 80 | 104 | 77.2% | |
Long term debt | Rs m | 3 | 0 | - | |
Total assets | Rs m | 135 | 11,542 | 1.2% | |
Interest coverage | x | 7.0 | 17.5 | 40.3% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.8 | 0.4 | 176.0% | |
Return on assets | % | 3.1 | 0.5 | 609.3% | |
Return on equity | % | 4.3 | 52.4 | 8.2% | |
Return on capital | % | 6.5 | 75.7 | 8.6% | |
Exports to sales | % | 0 | 47.1 | 0.0% | |
Imports to sales | % | 0 | 59.8 | 0.0% | |
Exports (fob) | Rs m | NA | 2,402 | 0.0% | |
Imports (cif) | Rs m | NA | 3,051 | 0.0% | |
Fx inflow | Rs m | 0 | 2,402 | 0.0% | |
Fx outflow | Rs m | 0 | 3,051 | 0.0% | |
Net fx | Rs m | 0 | -648 | -0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2 | 205 | 1.1% | |
From Investments | Rs m | -7 | NA | 1,641.9% | |
From Financial Activity | Rs m | NA | NA | -32.4% | |
Net Cashflow | Rs m | -5 | 204 | -2.3% |
Indian Promoters | % | 3.1 | 1.1 | 281.1% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | 25.0% | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 96.9 | 98.9 | 98.0% | |
Shareholders | 6,193 | 15,587 | 39.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare FRASER & COMPANY With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA NOVARTIS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | FRASER & COMPANY | REMEDIUM LIFECARE |
---|---|---|
1-Day | 1.19% | -4.20% |
1-Month | 4.49% | -9.47% |
1-Year | -3.76% | -65.16% |
3-Year CAGR | -3.23% | 123.77% |
5-Year CAGR | -10.73% | 107.38% |
* Compound Annual Growth Rate
Here are more details on the FRASER & COMPANY share price and the REMEDIUM LIFECARE share price.
Moving on to shareholding structures...
The promoters of FRASER & COMPANY hold a 3.1% stake in the company. In case of REMEDIUM LIFECARE the stake stands at 1.1%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of FRASER & COMPANY and the shareholding pattern of REMEDIUM LIFECARE.
Finally, a word on dividends...
In the most recent financial year, FRASER & COMPANY paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
REMEDIUM LIFECARE paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of FRASER & COMPANY, and the dividend history of REMEDIUM LIFECARE.
After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.